re: Ann: Regeneus to fast-track human cells u...
I was just having a read through this announcement. The significance of this Japanese policy will be great for companies like Regneneus, While the loops and hurdles in other countries giving approval for therapeutic medicine remain, we will be given the speed lane after minimal positive trial results. The Japanese healthcare market is the second largest in the world.(As stated in the announcement). This could take years off the approval phases.
I would appreciate comment from anyone with a better knowledge of the possible time frames for approvals,
. The fact that there seems to be no side affects from stemcell therapy may shorten the the red tape to final approvals.???. Info please.!
.
RGS Price at posting:
39.0¢ Sentiment: LT Buy Disclosure: Held